Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
US12130293B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2022 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | May 17, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to methods of diagnosing, prognosing, or monitoring or staging the progression of non-alcoholic fatty liver disease (NAFLD) using biomarkers. The invention also relates to a method of scoring to determine the severity of NAFLD, and a method of treating NAFLD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.